News
US FDA accepts for review Milestone Pharma’s response to CRL for Cardamyst nasal spray: Montreal Monday, July 14, 2025, 11:00 Hrs [IST] Milestone Pharmaceuticals Inc., a biophar ...
MyChesCo on MSN5h
FDA Publishes Over 200 Complete Response Letters to Increase Drug Approval TransparencyIn a landmark move to improve transparency and modernize regulatory processes, the U.S. Food and Drug Administration (FDA) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback